Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.30
-0.16 (-2.48%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Taysha Gene Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,810 | 1,507 | 355 | 331 | 141 | 448 | |
| Market Cap Growth | 654.54% | 324.92% | 7.14% | 134.50% | -68.52% | -55.28% | |
| Enterprise Value | 1,561 | 1,278 | 260 | 227 | 170 | 314 | |
| Last Close Price | 6.30 | 5.50 | 1.73 | 1.77 | 2.26 | 11.65 | |
| PS Ratio | 185.23 | 154.16 | 42.55 | 21.42 | 56.40 | - | |
| PB Ratio | 7.27 | 6.10 | 4.96 | 4.42 | 148.70 | 4.70 | |
| P/TBV Ratio | 7.33 | 6.10 | 4.96 | 4.42 | 148.70 | 4.70 | |
| EV/Sales Ratio | 159.69 | 130.80 | 31.19 | 14.67 | 67.98 | - | |
| Debt / Equity Ratio | 0.28 | 0.28 | 0.88 | 0.82 | 63.15 | 0.66 | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.06 | -1.10 | -29.45 | -0.90 | |
| Net Debt / EBITDA Ratio | 2.28 | 2.28 | 0.89 | 1.18 | 0.22 | 0.50 | |
| Net Debt / FCF Ratio | 2.66 | 2.66 | 0.93 | 1.08 | 0.26 | 0.65 | |
| Asset Turnover | 0.04 | 0.04 | 0.05 | 0.10 | 0.02 | - | |
| Quick Ratio | 12.04 | 12.04 | 5.30 | 3.92 | 1.40 | 2.88 | |
| Current Ratio | 12.23 | 12.23 | 5.42 | 4.08 | 1.54 | 3.08 | |
| Return on Equity (ROE) | -68.45% | -68.45% | -121.94% | -294.04% | -344.67% | -100.68% | |
| Return on Assets (ROA) | -27.42% | -27.42% | -32.51% | -29.84% | -46.30% | -45.80% | |
| Return on Capital Employed (ROCE) | -34.90% | -34.90% | -64.60% | -52.50% | -198.50% | -106.80% | |
| Earnings Yield | -6.02% | -7.23% | -25.19% | -33.71% | -117.64% | -38.94% | |
| FCF Yield | -5.18% | -6.23% | -23.02% | -23.23% | -77.25% | -29.53% | |
| Buyback Yield / Dilution | -27.82% | -27.82% | -115.41% | -164.20% | -16.74% | -113.13% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.